Literature DB >> 10468289

Role of a proteolysis-inducing factor (PIF) in cachexia induced by a human melanoma (G361).

P T Todorov1, W N Field, M J Tisdale.   

Abstract

Human melanoma, G361, which induces cachexia in nude mice, has been shown to produce a proteolysis-inducing factor (PIF) of Mr 24000, which is immunologically identical to that isolated from a cachexia-inducing murine tumour (MAC16). Biosynthetic labelling of G361 cells using a combination of [35S]sulphate and [6-3H]glucosamine gave a single component of Mr 24000 after affinity chromatography employing a murine monoclonal antibody. The material contained both radiolabels and, after digestion with peptide N-glycosidase F, two fragments were produced of Mr 14000 and 10000 also containing both radiolabels. Digestion with O-glycosidase produced three fragments of Mr 14000, 6000 and 4000, the first two of which contained both radiolabels, while the third only contained 3H. This digestion pattern is the same as that previously observed with PIF from the MAC16 tumour and is commensurate with one N-linked sulphated oligosaccharide chain of Mr 10000, one O-linked sulphated oligosaccharide chain of Mr 6000 and a central polypeptide chain of Mr 4000 with some residual carbohydrate. When PIF from G361 cells was administered to female NMRI mice (20 g) a pronounced depression of body weight (1.36+/-0.36 g; P < 0.0001 from control) was observed over a 24 h period without a decrease in either food or water consumption. Body composition analysis showed a significant decrease in the non-fat carcass mass without a change in carcass fat or body water. This result suggests that depletion of lean body mass in mice bearing G361 melanoma arises from the production of PIF.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468289      PMCID: PMC2374268          DOI: 10.1038/sj.bjc.6690590

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  19 in total

Review 1.  The Sir David Cuthbertson Medal Lecture 1991. The mechanisms and treatment of weight loss in cancer.

Authors:  K C Fearon
Journal:  Proc Nutr Soc       Date:  1992-08       Impact factor: 6.297

2.  Effects of injected leukemia inhibitory factor on hematopoietic and other tissues in mice.

Authors:  D Metcalf; N A Nicola; D P Gearing
Journal:  Blood       Date:  1990-07-01       Impact factor: 22.113

3.  Evidence for the involvement of interleukin 6 in experimental cancer cachexia.

Authors:  G Strassmann; M Fong; J S Kenney; C O Jacob
Journal:  J Clin Invest       Date:  1992-05       Impact factor: 14.808

Review 4.  Cachectin and tumour necrosis factor as two sides of the same biological coin.

Authors:  B Beutler; A Cerami
Journal:  Nature       Date:  1986 Apr 17-23       Impact factor: 49.962

5.  Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes.

Authors:  M K Marshall; W Doerrler; K R Feingold; C Grunfeld
Journal:  Endocrinology       Date:  1994-07       Impact factor: 4.736

6.  Regulation of food intake and hepatic protein synthesis by recombinant-derived cytokines.

Authors:  L L Moldawer; C Andersson; J Gelin; K G Lundholm
Journal:  Am J Physiol       Date:  1988-03

7.  Characterization of a cancer cachectic factor.

Authors:  P Todorov; P Cariuk; T McDevitt; B Coles; K Fearon; M Tisdale
Journal:  Nature       Date:  1996-02-22       Impact factor: 49.962

8.  Anti-interferon-gamma antibody treatment, growth of Lewis lung tumours in mice and tumour-associated cachexia.

Authors:  P Matthys; H Heremans; G Opdenakker; A Billiau
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

9.  Cancer cachexia syndrome developed in nude mice bearing melanoma cells producing leukemia-inhibitory factor.

Authors:  M Mori; K Yamaguchi; S Honda; K Nagasaki; M Ueda; O Abe; K Abe
Journal:  Cancer Res       Date:  1991-12-15       Impact factor: 12.701

10.  Mechanism of muscle protein degradation in cancer cachexia.

Authors:  K L Smith; M J Tisdale
Journal:  Br J Cancer       Date:  1993-08       Impact factor: 7.640

View more
  13 in total

Review 1.  Anorexia-Cachexia syndrome in cancer: implications of the ubiquitin-proteasome pathway.

Authors:  Carlos Camps; Vega Iranzo; Roy M Bremnes; Rafael Sirera
Journal:  Support Care Cancer       Date:  2006-07-04       Impact factor: 3.603

2.  Muscle cachexia is regulated by a p53-PW1/Peg3-dependent pathway.

Authors:  Martina Schwarzkopf; Dario Coletti; David Sassoon; Giovanna Marazzi
Journal:  Genes Dev       Date:  2006-12-15       Impact factor: 11.361

3.  Understanding tumor anabolism and patient catabolism in cancer-associated cachexia.

Authors:  Alejandro Schcolnik-Cabrera; Alma Chávez-Blanco; Guadalupe Domínguez-Gómez; Alfonso Dueñas-González
Journal:  Am J Cancer Res       Date:  2017-05-01       Impact factor: 6.166

4.  Cancer cachexia is regulated by selective targeting of skeletal muscle gene products.

Authors:  Swarnali Acharyya; Katherine J Ladner; Lori L Nelsen; Jeffrey Damrauer; Peter J Reiser; Steven Swoap; Denis C Guttridge
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

5.  The survival-promoting peptide Y-P30 enhances binding of pleiotrophin to syndecan-2 and -3 and supports its neuritogenic activity.

Authors:  Peter Landgraf; Petra Wahle; Hans-Christian Pape; Eckart D Gundelfinger; Michael R Kreutz
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

6.  Dermcidin expression in hepatic cells improves survival without N-glycosylation, but requires asparagine residues.

Authors:  A G Lowrie; S J Wigmore; D J Wright; I D Waddell; J A Ross
Journal:  Br J Cancer       Date:  2006-06-05       Impact factor: 7.640

Review 7.  Molecular and cell-based therapies for muscle degenerations: a road under construction.

Authors:  Emanuele Berardi; Daniela Annibali; Marco Cassano; Stefania Crippa; Maurilio Sampaolesi
Journal:  Front Physiol       Date:  2014-04-08       Impact factor: 4.566

8.  Additive Value of Preoperative Sarcopenia and Lymphopenia for Prognosis Prediction in Localized Pancreatic Ductal Adenocarcinoma.

Authors:  Christelle d'Engremont; Julienne Grillot; Julie Raillat; Dewi Vernerey; Lucine Vuitton; Stéphane Koch; Célia Turco; Bruno Heyd; Guillaume Mouillet; Quentin Jacquinot; Christophe Borg; Angélique Vienot
Journal:  Front Oncol       Date:  2021-05-27       Impact factor: 6.244

9.  Metabolic and morphological alterations induced by proteolysis-inducing factor from Walker tumour-bearing rats in C2C12 myotubes.

Authors:  Claudia L Yano; Gislaine Ventrucci; William N Field; Michael J Tisdale; Maria Cristina C Gomes-Marcondes
Journal:  BMC Cancer       Date:  2008-01-28       Impact factor: 4.430

10.  Expression of the proteolysis-inducing factor core peptide mRNA is upregulated in both tumour and adjacent normal tissue in gastro-oesophageal malignancy.

Authors:  D A C Deans; S J Wigmore; H Gilmour; M J Tisdale; K C H Fearon; J A Ross
Journal:  Br J Cancer       Date:  2006-03-13       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.